SCHEMBL4742707

SCHEMBL4742707

Cc1cccc2c1CC(c1ccccc1)C2=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.60
CYP19A1 P11511 6/20 0.47
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HTR2B P41595 2/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
ALDH1A1 P00352 1/20 0.39
ALDH2 P05091 1/20 0.39
PARP1 P09874 1/20 0.39
PARP10 Q53GL7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5951389 0.82 ACHE (0.51) ACHECYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL1582845 0.81 CYP19A1 (0.43) ACHECYP19A1HTR2BTSHRKMT2A
SCHEMBL14939214 0.81 ACHE (0.62) ACHECYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL5951729 0.80 CYP19A1 (0.45) ACHECYP19A1HTR2BTSHRKMT2A
SCHEMBL14939420 0.80 CYP19A1 (0.45) ACHECYP19A1HTR2BTSHRKMT2A
SCHEMBL14940317 0.80 CYP19A1 (0.57) ACHECYP19A1HTR2BTSHRKMT2A
SCHEMBL6936179 0.75 ACHE (1.00) ACHEHTR2BHTR2AHTR2CALDH1A1
SCHEMBL30666460 0.75 ACHE (1.00) ACHEHTR2BHTR2AHTR2CALDH1A1
SCHEMBL29165047 0.74 MAOB (0.51) ACHECYP19A1LMNACYP3A4MAPT
SCHEMBL25269938 0.74 ACHE (0.66) ACHEHTR2BKMT2AHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013068785-A1 INDANONE AND INDANDIONE DERIVATIVES AND HETEROCYCLIC ANALOGS ACTELION PHARMACEUTICALS LTD (CH) 2013-05-16 WO disclosed
WO-2008115141-A1 4, 5-DIHYDRO-1,3-THIAZOL-2-AMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-09-25 WO disclosed